Guillain–Barré syndrome in Colombia: where do we stand now?
Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) inf...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24280
- Acceso en línea:
- https://doi.org/10.1007/s12026-016-8816-8
https://repository.urosario.edu.co/handle/10336/24280
- Palabra clave:
- Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_020de57b19f13867f7f893f5610b4b8b |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/24280 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
06ca03f0-d941-410a-8ff1-339af01ee4d3f93a35c6-cfd6-477e-af82-501c638fca6d00775a99-006f-4214-aeab-93e462d739348002bf3a-1fbf-4a74-9722-32633fa8878d194747786002020-05-26T00:11:05Z2020-05-26T00:11:05Z2017Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York.application/pdfhttps://doi.org/10.1007/s12026-016-8816-80257277Xhttps://repository.urosario.edu.co/handle/10336/24280engHumana Press Inc.81No. 172Immunologic ResearchVol. 65Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 72-81https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978870287&doi=10.1007%2fs12026-016-8816-8&partnerID=40&md5=5e3da82270f488d17b93e77e82f2d49dAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCorticosteroidCorticotropinImmunoglobulinPrednisoneAcute inflammatory demyelinating polyneuropathyAcute motor axonal neuropathyArticleAutoimmune diseaseColombiaDeep vein thrombosisDrug megadoseDysautonomiaElectromyographyGastrointestinal infectionGraves diseaseGuillain barre syndromeHumanIncidenceIntervention studyLiteratureLung embolismMeta analysisMuscle strengthMuscle weaknessNerve conductionOutcome assessmentPeripheral nervous systemPlasmapheresisPriority journalSystematic reviewUrinary tract infectionVaccinationVentilator associated pneumoniaZika virusColombiaGuillain barre syndromeImmunologyPathophysiologyColombiaGuillain-barre syndromeHumansAnti-gangliosides antibodiesGuillain–barré syndromeLatin americaZika virusGuillain–Barré syndrome in Colombia: where do we stand now?articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Mahecha, María P.Ojeda, ErnestoVega, Daniel A.Sarmiento-Monroy, Juan C.Anaya, Juan-Manuel10336/24280oai:repository.urosario.edu.co:10336/242802022-05-02 07:37:13.599361https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title |
Guillain–Barré syndrome in Colombia: where do we stand now? |
spellingShingle |
Guillain–Barré syndrome in Colombia: where do we stand now? Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus |
title_short |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_full |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_fullStr |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_full_unstemmed |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_sort |
Guillain–Barré syndrome in Colombia: where do we stand now? |
dc.subject.keyword.spa.fl_str_mv |
Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus |
topic |
Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus |
description |
Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York. |
publishDate |
2017 |
dc.date.created.spa.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:11:05Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:11:05Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1007/s12026-016-8816-8 |
dc.identifier.issn.none.fl_str_mv |
0257277X |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/24280 |
url |
https://doi.org/10.1007/s12026-016-8816-8 https://repository.urosario.edu.co/handle/10336/24280 |
identifier_str_mv |
0257277X |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
81 |
dc.relation.citationIssue.none.fl_str_mv |
No. 1 |
dc.relation.citationStartPage.none.fl_str_mv |
72 |
dc.relation.citationTitle.none.fl_str_mv |
Immunologic Research |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 65 |
dc.relation.ispartof.spa.fl_str_mv |
Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 72-81 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978870287&doi=10.1007%2fs12026-016-8816-8&partnerID=40&md5=5e3da82270f488d17b93e77e82f2d49d |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Humana Press Inc. |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167666448924672 |